Bellerophon Reports 2015 Third Quarter Operational and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
Bellerophon Therapeutics (BLPH) Tops Q3 EPS by 8c
November 12, 2015 6:18 AM ESTBellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.86), $0.08 better than the analyst estimate of ($0.94).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
... More